Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
43°
Cloudy
Site search
Search
Menu
Subscribe
Home
News
Local News
Sports
Obituaries
Photos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Explore the Sheyenne
Best of 2023
Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Merck & Co
(NY:
MRK
)
129.22
-0.90 (-0.69%)
Official Closing Price
Updated: 7:00 PM EDT, Apr 30, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Merck & Co
< Previous
1
2
...
28
29
30
31
32
33
34
35
36
...
65
66
Next >
Looking At Merck & Co's Recent Whale Trades
September 22, 2022
A whale with a lot of money to spend has taken a noticeably bearish stance on Merck & Co. Looking at options history for Merck & Co (NYSE:MRK) we detected 13 strange trades.
Via
Benzinga
Nanobiotix Establishes Recommended Dose For Registrational Study Of Head & Neck Combo Therapy Trial
September 22, 2022
Nanobiotix (NASDAQ: NBTX) determined the recommended phase 2 dose (RP2D) of the NBTXR3 combo regime for inoperable locoregional recurrent or recurrent and metastatic head and neck squamous cell...
Via
Benzinga
Why Is Evaxion Biotech (EVAX) Stock Up Today?
September 21, 2022
Today's news that Evaxion Biotech has enrolled its first patient in a key clinical trial has sent shares of EVAX stock soaring today.
Via
InvestorPlace
3 Stocks That Could Rocket on Biden’s Cancer Moonshot
September 20, 2022
Joe Biden’s cancer moonshot gave some of the drug companies a big shot in the arm. These three stocks all are doing big things in oncology.
Via
InvestorPlace
Merck To Start New Islatravir HIV Trials With Lower Dose After FDA Hold
September 20, 2022
Via
Benzinga
Stocks Secure Wins In Last Hour Of Trading
September 19, 2022
After flipping above and below breakeven for the better part of the afternoon, the major indexes jumped to a positive finish, the Dow closing with a confident triple-digit win.
Via
Talk Markets
Immutep Issues Development Update For Its Lead Cancer Candidate
September 14, 2022
Via
Benzinga
Analyst Ratings for Merck & Co
September 12, 2022
Analysts have provided the following ratings for Merck & Co (NYSE:MRK) within the last quarter:
Via
Benzinga
Take-Two Gets Beat Down After Leak of Its Popular Grand Theft Auto VI
September 19, 2022
(Monday Market Open) Equity index futures are pointing to a lower open as the Federal Open Market Committee meets tomorrow and announces their interest rate decision on Wednesday.
Via
Benzinga
7 Penny Stocks That Actually Have a Buy Rating
September 19, 2022
Penny stocks are always a risky proposition. However, investors can still find penny stocks with buy ratings right now.
Via
InvestorPlace
Why Hedge Funds Are Piling In These 2 High Yielding Stocks
September 18, 2022
As we move further into the second half of the year, many investors will find themselves repositioning to better allocate their investments to mitigate risks. Some investors prefer to take positions in...
Via
Benzinga
7 Undervalued Stock Picks to Beat the September Market Slump
September 16, 2022
While seeing a wave of red ink isn’t fun during the middle of a steep selloff, it also opens opportunities for undervalued stock picks.
Via
InvestorPlace
Something Unusual Is Happening Right Now With Biotech Stocks Like Catalyst, Vertex, Neurocrine And BioMarin
September 15, 2022
The market is struggling, yet biotech stocks are acting like it's good times again. Here's why.
Via
Investor's Business Daily
What Are Whales Doing With Merck & Co
September 14, 2022
Someone with a lot of money to spend has taken a bullish stance on Merck & Co (NYSE:MRK). And retail traders should know. We noticed this today when the big position showed up on publicly available...
Via
Benzinga
Evercore ISI Group Boosts PT On This Stock By Around 400%, Plus This Analyst Predicts $100 For Merck
September 14, 2022
Berenberg raised the price target for Merck & Co., Inc. (NYSE: MRK) from $95 to $100. Merck shares rose 0.7% to $86.22 in pre-market trading.
Via
Benzinga
Important Biotech Catalysts For September 13, 2022 - End Of The Day Summary
September 13, 2022
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 14, 2022
September 14, 2022
Upgrades For Iris Energy Ltd (NASDAQ:IREN), Compass Point upgraded the previous rating of Neutral to Buy. The current stock performance of Iris Energy shows a 52-week-high of $17.97 and a 52-week-low...
Via
Benzinga
Merck Secures Canadian Regulatory Nod For KEYTRUDA In Skin Cancer After Resection
September 13, 2022
Health Canada has granted approval for Merck’s (NYSE: MRK) KEYTRUDA (pembrolizumab) for the adjuvant treatment of adult and pediatric (12 years and older) patients with stage IIB or IIC melanoma...
Via
Benzinga
After FDA Regulatory Setback, Penny Stock ObsEva Cuts 70% Of Its Staff
September 13, 2022
Via
Benzinga
This Is What Whales Are Betting On Merck & Co
September 12, 2022
A whale with a lot of money to spend has taken a noticeably bearish stance on Merck & Co. Looking at options history for Merck & Co (NYSE:MRK) we detected 17 strange trades.
Via
Benzinga
BP To $47? Plus UBS Sees $2,260 For This Stock
September 12, 2022
Piper Sandler boosted the price target for BP p.l.c. (NYSE: BP) from $44 to $47. BP shares rose 2.1% to trade at $32.34 on Monday.
Via
Benzinga
Five-Year Data For Merck's Keytruda Plus Chemo Shows Sustained Survival Benefit In Lung Cancer Patients
September 12, 2022
Via
Benzinga
Merck's Keytruda Combo Trial Fails To Meet Primary Goal In Liver Cancer
September 12, 2022
Via
Benzinga
Merck Gambled With Keytruda In 2011 — How That Jump Is Still Paying Off Today
September 11, 2022
In two new studies, Keytruda doubled patients' survival rate after five years.
Via
Investor's Business Daily
Important Biotech Catalysts For September 9, 2022 - End Of The Day Summary
September 09, 2022
Via
Benzinga
AstraZeneca-Merck's Lynparza Treatment Shows Long-Term Survival In Ovarian Cancer
September 09, 2022
Via
Benzinga
Top Financial Stories Thursday, September 1: Netflix Weighs Charging High Sum For Ads, Self Harm posts Grow On Twitter, California Fast-Food Bill Faces Industry Backlash...
September 01, 2022
Wall Street Journal
Via
Benzinga
Novartis Appoints Merck Executive As Research Head
September 01, 2022
Via
Benzinga
With Approval For Dengue Vaccine, Takeda May Find It Challenging To Compete Bigger Rivals: Report
August 30, 2022
Via
Benzinga
10 Biotech Stocks Are Up 40% Or More This Year, Including Karuna, Axsome And Others
August 29, 2022
These names are benefitting from M&A, clinical data and promising regulatory actions.
Via
Investor's Business Daily
< Previous
1
2
...
28
29
30
31
32
33
34
35
36
...
65
66
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.